Insulet Corporation announced that its Omnipod 5 App for iPhone is now compatible with the Dexcom G7 Continuous Glucose Monitoring (CGM) System for all U.S. users. This integration allows users to control their Omnipod 5 Automated Insulin Delivery (AID) System directly from their iPhone.
This combines the benefits of tubeless AID and Dexcom's latest CGM technology, offering additional convenience. The app provides full control, including the ability to bolus, change a Pod, and adjust settings.
This integration with Dexcom G7, a leading CGM system, significantly enhances the convenience and choice for Omnipod 5 users in the U.S. By enabling full control from an iPhone, it reduces the number of devices users need to carry, improving the overall user experience. This product enhancement is expected to drive further adoption and retention, strengthening Insulet's competitive position in the automated insulin delivery market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.